Companies / Denali Therapeutics Inc. / Activity
Activity — Denali Therapeutics Inc.
13 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Privium Fund Management B.V. 13F manager | New | Common stock | $5.91M | +230K | 229,857 0.14% of shares | medium |
| Q1 2026 as of | Great Lakes Advisors, LLC 13F manager | New | Common stock | $4.36M | +227K | 227,110 0.14% of shares | low |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $3.75M | +195K | 195,108 0.12% of shares | low |
| Q3 2025 as of | Boxer Capital Management, LLC 13F manager | New | Common stock | $3.63M | +250K | 250,000 0.16% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $586.9K | +31K | 30,570 0.02% of shares | low |
| Q1 2026 as of | Amundi 13F manager | New | Common stock | $357.2K | +19K | 18,604 0.01% of shares | low |
| Q1 2026 as of | Mariner, LLC 13F manager | New | Common stock | $348.1K | +18K | 18,131 0.01% of shares | low |
| Q1 2026 as of | Contravisory Investment Management, Inc. 13F manager | New | Common stock | $277.5K | +14K | 14,451 <0.01% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $93.6K | +6K | 5,670 <0.01% of shares | low |
| Q2 2026 as of | Meeder Asset Management Inc 13F manager | New | Common stock | $3.7K | +142 | 142 <0.01% of shares | low |
| Q3 2021 as of | Leonteq Securities AG 13F manager | New | Common stock | $3.3K | +65 | 65 <0.01% of shares | low |
| Q2 2025 as of | Elevation Point Wealth Partners, LLC 13F manager | New | Common stock | $2.8K | +201 | 201 <0.01% of shares | low |
| Q2 2026 as of | CVA Family Office, LLC 13F manager | New | Common stock | $2.2K | +86 | 86 <0.01% of shares | low |